Benitec Biopharma Ltd ADR (BNTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,879 | -5,970 | -2,718 | -8,274 | -5,339 |
| Depreciation Amortization | 179 | 112 | 45 | 190 | 150 |
| Accounts receivable | 21 | 28 | 27 | 2,396 | 2,494 |
| Accounts payable and accrued liabilities | 1,214 | -427 | -119 | -1,696 | -1,197 |
| Other Working Capital | 1,524 | -44 | 228 | 126 | 479 |
| Other Operating Activity | -734 | 615 | 177 | -277 | -977 |
| Operating Cash Flow | $-7,675 | $-5,686 | $-2,360 | $-7,535 | $-4,390 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -362 | -347 | -173 | -94 | -81 |
| Investing Cash Flow | $-362 | $-347 | $-173 | $-94 | $-81 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 11,497 | 11,494 | N/A | 2,250 | 2,250 |
| Other Financing Activity | -1,643 | -1,643 | 0 | -480 | -480 |
| Financing Cash Flow | $9,854 | $9,851 | $N/A | $1,770 | $1,770 |
| Exchange Rate Effect | 370 | 391 | 182 | -58 | -1,617 |
| Beginning Cash Position | 9,801 | 9,801 | 9,801 | 15,718 | 15,718 |
| End Cash Position | 11,988 | 14,010 | 7,450 | 9,801 | 11,400 |
| Net Cash Flow | $2,187 | $4,209 | $-2,351 | $-5,917 | $-4,318 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,675 | -5,686 | -2,360 | -7,535 | -4,390 |
| Capital Expenditure | -362 | -347 | -173 | -95 | -82 |
| Free Cash Flow | -8,037 | -6,033 | -2,533 | -7,630 | -4,472 |